Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type

INTRODUCTION: Factors affecting trastuzumab efficacy in advanced gastric cancer (GC) are largely unknown. Heterogeneity is a notable feature of HER2 in GC. Whether the heterogeneity influences trastuzumab efficacy is still unknown. RESULTS: The HER2(homogeneous) group and HER2(heterogeneous) group s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Xu, Chen, Liu, Yalan, Jiang, Dongxian, Li, Qian, Ge, Xiaowen, Zhang, Ying, Huang, Jie, Su, Jieakesu, Ji, Yuan, Hou, Jun, Lu, Shaohua, Hou, Yingyong, Liu, Tianshu
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464860/
https://ncbi.nlm.nih.gov/pubmed/28388541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16567
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados